Eisai sales and marketing update

Eisai's Eisai Europe Ltd. subsidiary launched Zebinix eslicarbazepine acetate in Sweden as an adjunct therapy for epilepsy in adults with partial-onset seizures with or without secondary generalization. The company said the product will receive full reimbursement from Swedish health authorities. Details were not disclosed. ...